Screener
Bruker BRKR Bsi Biospin — Operating Income
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bruker in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Bruker’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:24 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335226
| Line item | Three Months Ended June 30, 2026 / BSI Bio Spin | Three Months Ended June 30, 2026 / BSI CALID | Three Months Ended June 30, 2026 / BSI NANO | Three Months Ended June 30, 2026 / BEST | Three Months Ended June 30, 2026 / Total | Three Months Ended June 30, 2025 / BSI Bio Spin | Three Months Ended June 30, 2025 / BSI CALID | Three Months Ended June 30, 2025 / BSI NANO | Three Months Ended June 30, 2025 / BEST | Three Months Ended June 30, 2025 / Total |
|---|---|---|---|---|---|---|---|---|---|---|
| Cost of revenue | $94.1 | $126.1 | $123.7 | $59.8 | $403.7 | $108.1 | $125.6 | $125.6 | $52.3 | $411.6 |
| Selling, general and administrative | 38.4 | 79.3 | 68.6 | 5.8 | 192.1 | 40.9 | 76.9 | 72.7 | 5.7 | 196.2 |
| Research and development | 21.5 | 32.6 | 39.2 | 1.0 | 94.3 | 23.2 | 30.0 | 44.4 | 1.1 | 98.7 |
| Segment operating income | $41.7 | $72.3 | $29.8 | $7.6 | $151.4 | $23.1 | $53.3 | $9.4 | $7.2 | $93.0 |
| Reconciliation of Total operating income: | ||||||||||
| Corporate, elimination and other (a) | $32.8 | $21.1 | ||||||||
| Adjustments and reconciling items (b) | 183.9 | 60.0 | ||||||||
| Total consolidated operating (loss) income | $(65.3) | $11.9 |
ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Bruker's bsi biospin — operating income?
- Bruker (BRKR) reported bsi biospin — operating income of $41.7M in Q2 2026.
- How has Bruker's bsi biospin — operating income changed year-over-year?
- Bruker's bsi biospin — operating income increased by 80.5% year-over-year, from $23.1M to $41.7M.
- What is the long-term trend for Bruker's bsi biospin — operating income?
- Over 3 years (2021 to 2025), Bruker's bsi biospin — operating income has grown at a -0.4% compound annual growth rate (CAGR), from $158.2M to $156.5M.
- What does bsi biospin — operating income mean?
- This is the profit or loss generated by the BioSpin segment after deducting operating expenses from its revenue. It serves as the primary measure of the segment's operational profitability and management's ability to control costs. It excludes interest, taxes, and non-operating items, providing a clear view of core business performance.
Ask your AI about Bruker's bsi biospin — operating income.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude